This community-based prospective study examined the effects of viral infections and lifestyle habits on hepatocellular carcinoma (HCC) risk in Japan. A baseline survey was conducted for 981 males and 2,078 females in June 1992 and evaluated hepatitis B surface antigen, second-generation hepatitis C virus antibody, and history of cigarette smoking and habitual alcohol consumption. By March 1997,14 males and 8 females had been newly diagnosed with HCC. After controlling for gender and age by using the Cox model, the authors found that positivity for hepatitis B surface antigen (hazard ratio = 7.28, 95% confidence interval: 1.62, 32.61; p < 0.01) and positivity for high-titer hepatitis C virus antibody (hazard ratio = 40.38, 95% confidence interval: 11.71, 139.21; p < 0.001) were significantly associated with HCC risk, although a history of smoking or alcohol consumption was not significantly related to risk. There was a significant interaction on an additive scale for the risk of HCC development between high-titer hepatitis C virus antibody status and a history of smoking (p < 0.05) in spite of no significant interaction on a multiplicative scale. Although preventing the transmission of hepatitis viruses is most important for reducing the risk of HCC, intervention regarding lifestyle habits such as cigarette smoking should not go unheeded. Am J Epidemiol 2000;151:131-9.
10-30 percent of these cases in Japan have been related to hepatitis B virus (5-7), whereas more than 60 percent of HCC cases in Taiwan have been correlated with hepatitis B virus infection (8, 9) .
Although the major risk for HCC development has been attributed to these viral infections, data from various epidemiologic studies suggest that other risk factors such as male gender, history of cigarette smoking, and habitual alcohol consumption may also contribute to the development of HCC (5, (10) (11) (12) (13) (14) . It has been suggested (15) that the evolution of HCC is a multistage, multifactorial process, and research investigating the interactions of hepatitis B or C virus with lifestyle factors may provide further insight into the multifactorial etiology of HCC.
A considerable number of case-control studies (5, (9) (10) (11) (12) (13) (14) (16) (17) (18) (19) (20) as well as hospital-based prospective studies of patients with asymptotic virus positivity, chronic hepatitis, or liver cirrhosis (7, 21, 22) have been conducted to assess risk factors for HCC. Nevertheless, only a few community-based prospective studies have been carried out to investigate risk factors for HCC (8, (23) (24) (25) . Characteristic robustness is found in community-based prospective studies, especially when risk factors related to lifestyle habits are evaluated, because selection bias is less likely to arise. The main purpose of the present study was to examine the effect of viral infections and lifestyle habits, after adjustment for potential confounding variables, on the risk of HCC by using data from a community-based prospective study undertaken in K. Town, Japan.
MATERIALS AND METHODS

Study subjects
K. Town is located in Saga Prefecture, which is in the northern portion of the island of Kyushu in southwestern Japan. The population of K. Town was 18,274 in 1992. According to the Saga Prefectural Cancer Registry, the 1992 incidence rates of HCC in K. Town were 137.6 and 41.3 per 100,000 males and females, respectively; these rates were among the highest, even in Saga Prefecture.
The potential study group consisted of 4,904 subjects, every inhabitant aged 30 years or older whose mass screening program was supported financially by the national health insurance of Japan. These subjects were invited to participate in a mass screening for liver disorders offered by the government of K. Town. Employees of industries, public servants, and persons aged 29 years or younger were not included in the eligible study group because their screening programs were supported financially by different health insurance agencies. Among these subjects, 3,059 (62.4 percent, 981 males and 2,078 females) participated in the June 1992 screening. However, 7 males were excluded from the study because they already had HCC at the time of screening.
Baseline survey
A baseline survey was conducted in June 1992 during the screening for liver disorders. Study participants were evaluated for hepatitis B surface antigen (HBsAg) and second-generation hepatitis C virus antibody (HCVAb) by using the Abbott passive hemagglutination assay (Abbott Laboratories, Chicago, Illinois) and a conventional serologic liver function test. Participants also completed a structured questionnaire on their history of cigarette smoking and habitual alcohol consumption and their medical and family histories. Written, informed consent for a follow-up survey was obtained at that time.
A history of cigarette smoking was defined as having smoked a cumulative total of more than 100 cigarettes up to the time of the survey. If it was determined that a subject had a history of smoking, detailed information about the average number of cigarettes smoked per day and the duration (years) of smoking was obtained. Habitual alcohol consumption was defined as having regularly consumed at least one alcoholic drink per week. The average quantity of alcohol consumed per day from various kinds of alcoholic beverages such as sake, beer, whiskey, wine, and shochu (Japanese distilled spirits) was evaluated and was converted into the equivalent of glasses of Japanese sake. Duration of alcohol consumption was estimated as the number of years between the age at which habitual consumption began and the age at which habitual consumption ended or the survey was conducted.
According to Watanabe et al. (26) , Suzuki et al. (27) , and Mataki and Hino (28), the false-positive rates of HCVAb in terms of hepatitis C virus-RNA positivity were 27/34 (79.4 percent), 48/53 (90.6 percent), and 79/92 (85.9 percent), respectively, when the titer of HCVAb was 2 5 -2 n . However, according to these same authors, the false-positive rates were 0/120 (0 percent), 0/66 (0 percent), and 0/90 (0 percent), respectively, when the titer was higher than or equal to 2 12 . Consequently, we classified HCVAb-positive subjects as low titer (2 5 -2 n ) or high titer (higher than or equal to 2 12 ). On the basis of these classifications and when compared with subjects who were positive for lowtiter HCVAb, all subjects who were positive for hightiter HCVAb seemed to have actively replicating hepatitis C virus.
Follow-up survey
Study subjects were followed prospectively until March 1997. The mean (standard deviation) and median number of years of observation were 4.6 (0.65) and 4.8, respectively. Seventy-nine subjects (2.6 percent) were lost during the study period because they moved from the town.
During the follow-up period, most of the subjects were examined once a year during the mass screening for liver disorders offered by the government of K. Town. At that time, a conventional liver function test was conducted for serum aspartate aminotransferase, alanine aminotransferase, zinc sulfate turbidity, albumin, and total cholesterol. Subjects were advised to attend a clinic or hospital if their test results were abnormal and to provide the government of K. Town with the name of the clinic or hospital they visited. Then, in cooperation with the physicians in charge at the various medical institutions, one of the authors (M. M.) investigated these subjects' medical charts. A final diagnosis of HCC was determined by the physician in charge on the basis of either histologic findings or elevated alpha-fetoprotein levels combined with ultrasound scanning, computed tomography, and/or arteriography. Data were linked with the computer files of the Saga Prefectural Cancer Registry to confirm HCC in the study subjects. Information regarding vital statistics such as death, cause of death, date of death, and relocation from the town, all obtained through the town office, was also linked to the Registry.
Statistical analysis
Univariate and multivariate hazard ratios and 95 percent confidence intervals for potential risk factors for newly diagnosed HCC were estimated by using the Cox proportional hazards regression model (29) . The regression model tested for trend by creating an indicator (dummy) variable for each parameter (30) . Analysis was conducted by using the SAS software package (31) . The attributable risk was obtained by calculating the difference in incidence density (the number of new HCC cases divided by the total personyears of observation) between the exposed and the nonexposed groups, and the population attributable risk was obtained by multiplying the attributable risk by the proportion of the exposed group in a population (32) . A test for interaction on a multiplicative scale was conducted by using the Cox model. To test for interaction on an additive scale, T was calculated by using the method of Hogan et al. (33) . Statistical significance was determined by using a two-sided 5 percent level.
RESULTS
Characteristics at enrollment
The mean (standard deviation) age at enrollment was 58.1 (13.5) years for the 3,052 subjects and 61.6 (12.8) and 56.5 (13.5) years for the 974 males and 2,078 females, respectively. Characteristics of the study subjects at enrollment, including age strata, gender, HBsAg and HCVAb status, history of cigarette smoking and habitual alcohol consumption, history of liver disease in parents or siblings, and presence of chronic hepatitis or liver cirrhosis, are shown in table 1.
Fifty-four subjects (1.8 percent) were positive for HBsAg, and 275 (9.0 percent) and 380 (12.5 percent) subjects were positive for low-titer and high-titer HCVAb, respectively. Although 9 subjects (0.3 percent) in either the low-titer or high-titer group were positive for both HBsAg and HCVAb, this coincidental positivity was not significantly prevalent among these study subjects (p = 0.39).
Characteristics at endpoint
On the basis of 13,983.9 person-years, 22 subjects (14 males, 8 females) were newly diagnosed with different from the results that we actually showed later (not presented).
Risk factors for HCC
The risk of developing HCC was significantly higher for subjects in the age stratum 55-69 years at enrollment (hazard ratio (HR) = 7.27, 95 percent confidence interval (CI): 1.68, 31.45; p < 0.01) and for males (HR = 3.80, 95 percent CI: 1.60, 9.06; p< 0.01) (table 2) . However, a trend of increasing risk with increasing age was not significant. The risk was significantly higher for subjects who were positive for HBsAg (HR = 5.52, 95 percent CI: 1.29, 23.63; p < 0.05) and for subjects who were positive for high-titer HCVAb as compared with those who were negative for HCVAb (HR = 38.77, 95 percent CI: 11.42, 131.62; p < 0.001). Two subjects were positive for both HBsAg and low-titer HCVAb, and one had HCC. However, no HCC was observed in the 7 subjects who were positive for both HBsAg and high-titer HCVAb. Although HCC risk was significantly elevated among the 9 subjects who were positive for both HBsAg and HCVAb (HR = 17.06, 95 percent CI: 2.29, 126.82; p < 0.01), this hazard ratio was less than half that for high-titer HCVAb positivity. It is noteworthy that there was no HCC in the 273 subjects who were negative for HBsAg but positive for low-titer HCVAb.
As shown in table 2, the risk of developing HCC was significantly higher for subjects who had a history of cigarette smoking (HR = 3.75, 95 percent CI: 1.62, 8.68; p < 0.01) and subjects whose smoking index (cigarettes per day multiplied by years of smoking) was higher than or equal to 200 (HR = 3.76, 95 percent CI: 1.60, 8.86; p < 0.01). The risk was marginally significantly higher for subjects who had a history of habitual alcohol consumption (HR = 2.25, 95 percent CI: 0.97, 5.20; p = 0.06). However, the increased trend of risk based on the alcohol consumption index (the average drinks per day in terms of a glass of Japanese sake multiplied by years of drinking) was not significant (p for trend = 0.082). There was no significantly increased risk of HCC for subjects who had a history of liver disease in parents or siblings.
When the variables of gender and age were adjusted, the risk of developing HCC was significantly higher for subjects who were positive for HBsAg (adjusted HR = 7.28, 95 percent CI: 1.62, 32.61; p < 0.01) and subjects who were positive for high-titer HCVAb (adjusted HR = 40.38, 95 percent CI: 11.71, 139.21;/? < 0.001) (table 3). However, after adjustment for gender and age, the increased risks for developing HCC were not significant for subjects who had a history of either cigarette smoking or habitual alcohol consumption.
Per 10
5 person-years, the incidence density of HCC was 803.5 for subjects who were positive for HBsAg and 145.6 for subjects who were negative for HBsAg (p < 0.05) ( 
Interaction between viral infection and history of smoking or alcohol consumption
To evaluate HCC risk, we assessed the interaction on a multiplicative scale between the marker of hepatitis B or C virus infection and a history of smoking or alcohol consumption with and without adjustment for gender and age by the Cox model. However, a significant interaction on a multiplicative scale was not detected for any combination of these variables. We also assessed this interaction on an additive scale. As shown in table 5, the incidence density of HCC was considerably higher for the subjects with either HBsAg or high-titer HCVAb positivity and a positive history of smoking or alcohol consumption at the baseline survey. Furthermore, we found a significant additive interaction between high-titer HCVAb status and a history of cigarette smoking (T -0.080, 95 percent CI: 0.013, 0.147; p < 0.05), although there was no significant additive interaction between HBsAg status and a history of cigarette smoking or habitual alcohol consumption or between high-titer HCVAb status and a history of habitual alcohol consumption. A similar significant result was obtained for the additive interaction between high-titer HCVAb status and a history of cigarette smoking when the analysis was restricted to males (T = 0.089, 95 percent CI: 0.005, 0.174; p < 0.05 (data not shown)).
DISCUSSION
To our knowledge, this is the first report to prospectively assess the risk of both hepatitis B and C virus infection and a history of smoking or alcohol consumption for HCC in the community, and we were able to evaluate the population attributable risk of HCC for t The titer of HCVAb from 2* to 2" (passive hemagglutinatjon assay (PHA)). § This subject was also positive for HBsAg. H The titer of HCVAb £2" (PHA). # In terms of a glass of Japanese sake.
HBsAg and HCVAb positivity. Although a previous article described a community-based prospective study in Taiwan, a nested case-control design was used, and subjects were restricted to males (8) .
We have shown that HBsAg positivity and high-titer HCVAb positivity are both independent risk factors for the development of HCC. The positive rate of HBsAg (1.8 percent) among the subjects of this study was similar to that (about 2 percent) reported in Japan (34, 35) . In contrast, the positive rates of low-titer HCVAb (9.0 percent) and high-titer HCVAb (12.6 percent) among the present subjects were considerably higher than those among blood donors in Japan (0.5 percent and 0.8 percent for low-titer and high-titer HCVAb, respec- tively) (36) . Our study showed that the risk of hightiter HCVAb positivity for HCC was 7 times that of HBsAg positivity, and the population attributable risk of high-titer HCVAb positivity for HCC was more than 10 times that of HBsAg positivity. Consequently, it can be inferred that the high incidence rate of HCC in K. Town is profoundly associated with hepatitis C rather than hepatitis B virus infection.
Our univariate analysis suggested a positive association between both cigarette smoking and habitual alcohol consumption and the development of HCC, although it was not significant after adjustment for gender and age. A population-based prospective study X Proportion of the exposed group among the study subjects. § HBsAg, hepatitis B surface antigen; HCVAb, hepatitis C virus antibody.
1) The titer of HCVAb from 2° to 2 11 (passive hemagglutination assay (PHA)).
# The titer of HCVAb £2 12 (PHA). ** Positive for both HBsAg and HCVAb In either the low-titer or high-titer group.
of Japanese men revealed a significant association between the daily use of cigarettes (relative risk = 3.14) and consumption of alcohol (relative risk = 1.89) and the incidence of primary liver cancer (24) . A community-based prospective study of Taiwanese men also showed a relation between the quantity of cumulative cigarette use and alcohol consumption and the risk of HCC (25) . In addition, a substantial number of case-control studies or hospital-based prospective studies have also found a positive relation between cigarette use (10) (11) (12) and/or alcohol consumption (5, (11) (12) (13) (14) and the risk of HCC. Cigarette smoking or habitual alcohol consumption may account for a part of the gender difference in the incidence of HCC, although a suggested association of elevated testosterone levels with an increased risk of HCC (37, 38) cannot be ruled out.
According to Kleinbaum et al. (39) , in terms of interaction between two risk factors, deviations from additivity should be the focus whenever public health issues regarding a reduction in disease frequency are involved. On the other hand, these authors also stated that analysis of multiplicative models often contributes to the understanding of disease etiology. Our finding of a significant additive interaction between the marker of hepatitis C virus infection and a history of cigarette smoking may increase public health awareness of the necessity for intervention regarding smok- ing habits, even though our data did not show a significant interaction on a multiplicative scale. Previous case-control studies have presented evidence of an increased risk for the concurrent positivity of hepatitis B virus infection and cigarette smoking (11), hepatitis B virus infection and alcohol consumption (11, 13, 14) , hepatitis C virus infection and cigarette smoking (10, 12) , and hepatitis C virus infection and alcohol consumption (12, 14) . As these infections are at least partly responsible for the pathogenesis of HCC, it may be reasonable to suppose that hepatitis B or C virus infection causes continuous liver cell necrosis, hepatocyte regrowth, and eventual malignant transformation induced by mutational genetic error (15) . Cigarette smoking and alcohol consumption may promote these processes, because the liver is a target organ for chemicals in tobacco as well as ethanol. However, the detailed biologic mechanism of the effect of viral infection combined with lifestyle habits on HCC development remains to be explained.
Although there was one case of HCC among the nine subjects in our study who were positive for both HBsAg and HCVAb, the risk of dual viral infections for HCC development was less than half that of a single hepatitis C virus infection, and the population attributable risk of dual infections was less than a tenth that of a single hepatitis C virus infection. Consequently, we infer that coinfection plays a minor role in the pathogenesis of HCC in K. Town, in accordance with some of the previous reports (5, (40) (41) (42) . However, since other articles showed a positive interaction between hepatitis B and C virus infections and HCC development (10, 12, (16) (17) (18) (19) (20) 22) , extended observation may be required to obtain more conclusive findings on the interactive effect of coinfection in our study.
False-positive rates of HCVAb were reported as 80 percent or higher when the titer of HCVAb was 2 5 -2" as determined by passive hemagglutination assay (26) (27) (28) . In contrast, the false-positive rates were reported as 0 percent if the titer was higher than or equal to 2 12 by this same method (26) (27) (28) . Therefore, all subjects who were positive for high-titer HCVAb seemed to have actively replicating hepatitis C virus. On the contrary, it is possible that most of the subjects who were positive for low-titer HCVAb may indicate a history of hepatitis C virus infection (43) .
Because we did not obtain data on those subjects who were invited but chose not to participate in the study, we could not compare the characteristics of participants (62.4 percent) and nonparticipants (37.6 percent). Furthermore, employees of industries and public servants were not involved in the study. Additional surveys of those subjects as well as extended followups are needed to provide more conclusive evidence of an association between viral infection and lifestyle habits and the risk for developing HCC.
In conclusion, preventing the transmission of hepatitis viruses is most important in reducing the risk of developing HCC. However, intervention regarding lifestyle habits such as cigarette smoking should not go unheeded.
